NCT02273258View on ClinicalTrials.gov

A Study to Compare Pharmacokinetics and Pharmacodynamics of SAR342434 to Insulin Lispro in Subjects With Type 1 Diabetes

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Type 1 Diabetes
Interventions
DRUG

SAR342434

Pharmaceutical form:solution Route of administration: subcutaneous

DRUG

Insulin Lispro

Pharmaceutical form:solution Route of administration: subcutaneous

DRUG

Insulin Lispro

Pharmaceutical form:solution Route of administration: subcutaneous

Trial Locations (1)

Unknown

Sanofi Administrative Office, Frankfurt

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY